EUVIMEDEUVIMED entdecken
Multizentrische StudieFall-Kontroll-Studie

Non- Aspergillus invasive mould infections in liver transplant recipients: A French national retrospective case-control study, 2007–2021

Cléa Melenotte iD, Coralie Le Hyaric, Céline Guichon, Nada El Domiaty, François Lefebvre, Francois Durand, Christine Bonnal iD, Carole Vignals, Maxime Lefranc iD, Renaud Guérin, Maxime Moniot iD, Fanny Vuotto iD und 19 weitere

Medical Mycology · 2026

DOI: 10.1093/mmy/myaf119 ↗

Kurz gefasst

Multizentrische Studie in der Zeitschrift Medical Mycology, 2026. Verfasst von Cléa Melenotte und 30 weiteren Autor:innen. Beteiligte Einrichtung: Université Paris Cité, Hôpital Universitaire Necker-Enfants malades, Service de Maladies Infectieuses et Tropicales, Assistance Publique des Hôpitaux…. Hauptthemen laut MEDLINE: Liver Transplantation, Invasive Fungal Infections, Transplant Recipients. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 42 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Non-Aspergillus invasive mould infections (IMIs) are emerging in immunocompromised patients, and liver is the second most commonly organ transplanted worldwide.

Methods

We conducted a multicenter retrospective case-control (1:1) study of liver transplant (LT) recipients diagnosed with non-Aspergillus IMIs in France between January 2007 and December 2021.

Results

We identified 27/14 332 (0.18%) LT recipients with non-Aspergillus IMIs. Mucorales spp. (48%) were the most common pathogens, followed by Scedosporium spp. (14%), Fusarium spp. (14%), and other IMIs (25%). Lungs were the primary infection site, followed by soft tissues, abdomen, brain, sinuses, heart, and bone. Multivariate analysis showed that a Model for End-stage Liver Disease score > 20 prior to transplantation and primary antifungal prophylaxis (with echinocandins or fluconazole) tended to increase the risk of non-Aspergillus IMIs by nearly threefold ((adjusted Odd Ratio (aOR): 3.73, 95% Confidence Interval (CI) [0.90–15.45], P = .07) and (aOR: 3.93; 95% CI [0.94–16.42], P = .06), respectively). The 6-month mortality rate was 55%. In a Cox survival model, non-Aspergillus IMIs were associated with a threefold increase in mortality risk (Hazard Ratio (HR) : 3.82 [2.01–7.26] P < .001).

Conclusion

Non-Aspergillus IMIs are rare but highly fatal infections whose early diagnosis in high-risk liver-transplanted patients is essential. Whether or not recently available molecular tools for diagnosing non-Aspergillus IMIs will improve their prognosis in the liver transplantation setting remains to be studied.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Liver TransplantationInvasive Fungal InfectionsTransplant RecipientsHumansRetrospective StudiesFranceMaleFemaleCase-Control StudiesMiddle AgedAdultAgedRisk FactorsAntifungal AgentsImmunocompromised HostScedosporium

Stichwörter der Autor:innen

immunocompromised hostinvasive fungal infectionsmould infections

Substanzen

Antifungal Agents

Autor:innen und Institutionen

  • Université Paris Cité, Hôpital Universitaire Necker-Enfants malades, Service de Maladies Infectieuses et Tropicales, Assistance Publique des Hôpitaux de Paris, 75743 PARIS CEDEX 15, France.
  • Centre Médical de l'Institut Pasteur, Institut Pasteur, 75015 Paris, France.
  • Service de Maladies Infectieuses et Tropicales, Hôpitaux Universitaires de Strasbourg, 67091 Strasbourg cedex, France.
  • Service de réanimation médicale, Hospices Civils de Lyon, 69004 Lyon, France.
  • Université Paris Saclay, AP-HP Hôpital Paul Brousse, Hepato-Biliary Centre, Villejuif-France, INSERM UMR 1193, 94800 Villejuif, France.
  • Université de Helwan, Département de Médecine Endémique, 11795 Le Caire, Egypte.

ORCID-Profile: Cléa Melenotte, Christine Bonnal, Maxime Lefranc, Maxime Moniot, Fanny Vuotto, Pierre Tattevin, Nassim Kamar, Anne-Pauline Bellanger, Arnaud Fekkar, Agnès Lefort

Zitieren

APA

Melenotte, C., Le Hyaric, C., Guichon, C., El Domiaty, N., Lefebvre, F., Durand, F., Bonnal, C., Vignals, C., Lefranc, M., Guérin, R., Moniot, M., Vuotto, F., Loridant, S., Letscher-Bru, V., Tattevin, P., Conti, F., Monsel, A., Gangneux, J. P., Herbrecht, R., …, & Lefort, A. (2026). Non- Aspergillus invasive mould infections in liver transplant recipients: A French national retrospective case-control study, 2007–2021. Medical Mycology. https://doi.org/10.1093/mmy/myaf119

Vancouver

Melenotte C, Le Hyaric C, Guichon C, El Domiaty N, Lefebvre F, Durand F, et al. Non- Aspergillus invasive mould infections in liver transplant recipients: A French national retrospective case-control study, 2007–2021. Medical Mycology. 2026. doi:10.1093/mmy/myaf119

BibTeX
@article{Melenotte2026,
  author = {Melenotte, Cléa and Le Hyaric, Coralie and Guichon, Céline and El Domiaty, Nada and Lefebvre, François and Durand, Francois and Bonnal, Christine and Vignals, Carole and Lefranc, Maxime and Guérin, Renaud and Moniot, Maxime and Vuotto, Fanny and Loridant, Séverine and Letscher-Bru, Valérie and Tattevin, Pierre and Conti, Filomena and Monsel, Antoine and Gangneux, Jean-Pierre and Herbrecht, Raoul and Kamar, Nassim and Iriart, Xavier and Barbaz, Mathilde and Chesnay, Adélaïde and Weil, Delphine and Bellanger, Anne-Pauline and Fekkar, Arnaud and Botterel, Françoise and Saliba, Faouzi and Lortholary, Olivier and Danion, François and Lefort, Agnès},
  title = {Non- Aspergillus invasive mould infections in liver transplant recipients: A French national retrospective case-control study, 2007–2021},
  journal = {Medical Mycology},
  year = {2026},
  doi = {10.1093/mmy/myaf119}
}
Kostenlos starten →